{
    "nctId": "NCT04668521",
    "briefTitle": "Multifactorial Risk Assessment for Breast & Ovarian Cancer Risk Detection",
    "officialTitle": "Multifactorial Risk Assessment for Breast & Ovarian Cancer Risk Detection",
    "overallStatus": "TERMINATED",
    "conditions": "Adnexal Mass, Germline BRCA1 Gene Mutation, Germline BRCA2 Gene Mutation, Hereditary Breast and Ovarian Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 215,
    "primaryOutcomeMeasure": "OVA360",
    "eligibilityCriteria": "Key inclusion criteria:\n\n* Female subject\n* 18 years of age or older\n\nCohort A specific inclusion criteria:\n\n\u2022 Diagnosed with a pelvic mass\n\nCohort B specific inclusion criteria:\n\n* Diagnosed with a pelvic mass\n* Undergoing genetic testing through our commercial offering\n\nCohort C specific inclusion criteria:\n\n\u2022 Subject must not have an identifiable adnexal mass and may, or may not, have a family history or a known familial genetic abnormality (germ line or identified in family cancer i.e. somatic DNA mutation) associated with ovarian cancer.\n\nExclusion Criteria:\n\n* n/a",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}